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Background: Impaired ambulation, frequent falls, and prolonged immobilization combined 
with the high rate of vitamin D deficiency in people with multiple sclerosis (MS) could lead to 
an increased risk of hip fracture.
Methods: A retrospective cohort analysis of 20 years of the Nationwide Inpatient Sample 
(AHRQ.gov), a 20% stratified yearly sample of USA hospital admissions from the year 1988–2007, 
was performed. Based on International Classification of Diseases Ninth Revision (ICD9) codes, 
admissions with a primary diagnosis of acute hip fracture (ICD9 code 226.xx) and a secondary 
diagnosis of MS (ICD9 code 340) was identified. Indirect adjustment was used to compare 
the prevalence of MS in this population with that of the USA. Significance was set a priori at 
P,0.0001 due to the large number of records and multiple comparisons.
Results: A total of 1,066,404 hip fracture admissions were identified and 0.25% had MS. Those 
with MS were younger, had lower mortality rates (0.25% for people with MS versus 2.97% for 
those without MS, P,0.0001) and lower rates of discharge to nursing home or rehabilitation 
(69.25% for people with MS versus 72.17% for those without MS, P,0.0001). When compared 
with the population prevalence, the predicted prevalence of MS among patients with hip fracture 
was 2.844 (95% confidence interval [CI] 2.837–2.852) greater than expected when adjusted for 
age, 2.505 (95% CI 2.499–2.512) when adjusted for sex and age, and 2.175 (95% CI 2.168–2.182) 
when adjusted for race (white, black). Race was specified for only 65% of the sample.
Conclusion: In this nationwide sample of 20 years of hospital admissions in the USA, the 
prevalence of MS in the population with hip fracture was greater than twice that predicted, and 
MS patients suffered an acute fracture at an earlier age.
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Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease of the myelin sheath that 
results in progressive immobilization, muscle weakness, poor balance, and an increased 
risk of falls.1 When compared with healthy individuals, bone mineral density (BMD) in 
MS patients is significantly reduced.2 Multiple studies have found the femoral bone to 
be affected more and the bone disease to be more severe in the subset of patients with 
progressive MS.1,3,4 Furthermore, individuals with MS are exposed to steroid therapy 
and tend to have hypovitaminosis D from sun avoidance, contributing to bone loss.
The chronic nature of MS results in continued inflammation and activation of 
proinflammatory cytokines that disturb the balance between activation of osteoclas-
togenesis via osteoprotegerin and inhibition of osteoclastogenesis via receptor activa-
tor of nuclear factor kappa B ligand.3 This shift in continuum towards activation of 
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osteoclastogenesis results in ongoing bone loss. Coupled 
with physical inactivity, a chronic debilitating neurological 
disorder like MS leads to continued bone loss.5
Currently, patients are treated for osteoporosis based 
on history of a fragility fracture, BMD that is 2.5 standard 
deviations below the BMD of a young adult reference popu-
lation, and if the 10-year risk for a hip fracture is greater 
than 3% or the 10-year risk for a major osteoporotic fracture 
is greater than 20% based on the Fracture Risk Assessment 
Tool (FRAX).6 Although MS patients have higher rates 
of hip fracture as shown in previous studies1,7 and lower 
BMD when compared with patients without MS, FRAX 
may underestimate their risk because the calculation does 
not incorporate risk factors such as hypovitaminosis D and 
immobility.
The Nationwide Inpatient Sample (NIS, AHRQ.gov), 
is a 20% stratified sample of all acute care hospitalizations 
in the USA and is available from 1988 through 2011. This 
administrative dataset is used to study health care utiliza-
tion, hospital outcomes, and disease burden.4 The purpose 
of this study was to analyze acute hip fracture admissions 
over the last 20 years to determine if the prevalence of 
MS is increased in these cases compared with the general 
population.
Materials and methods
Population
Using retrospective cohort analysis of the NIS from 1988 
to 2007 and clinical classif ication software to redact 
 International Classification of Diseases Ninth Revision 
(ICD9) diagnostic and procedure codes, we set our inclusion 
criteria as those patients with a primary diagnosis of any type 
of hip fracture (ICD9 code 226.xx) and defined the cohorts 
by the secondary diagnosis of MS (ICD9 code 340). Initial 
analysis of the entire sample showed an age range from 
18 to 123 years, showing admissions that were likely to be 
miscoded or otherwise in error. We dropped the bottom and 
top 5% based on age. This methodology was used in prior 
publications by the authors.5
statistical analysis
To analyze the effects of time, we divided the records into four 
cohorts based on 5-year periods, ie, 1988–1992, 1993–1997, 
1998–2002, and 2003–2007. SAS version 9.1 software (SAS 
Institute Inc., Cary, NC, USA) was used for the analysis. 
Comparison of categorical data was  undertaken using 
χ2. Since initial analysis of the entire cohort showed that age 
was skewed, the Kruskal–Wallis test was used for  comparison. 
Unique identifiers in the NIS prevented identification of mul-
tiple admissions for the same subject.
The primary purpose of this study was to determine if 
MS was overrepresented in this population of individuals 
admitted for hip fracture. We used indirect standardization 
using the prevalence of MS based on the National Health 
Interview Survey by Noonan et al to determine the number of 
expected MS cases based on the entire cohort of hip fracture 
patients.8,9 This was calculated based on age, sex, and, for the 
proportion where race was available, for whites and blacks. 
Discharge disposition was a secondary outcome. Because 
of the large number of records and multiple comparisons, 
P was set a priori at ,0.0001.
Results
MS was a secondary diagnosis in 0.25% of 1,066,404 hip 
fracture admissions. Over the 20 years of this dataset, the pro-
portion of patients with MS increased from 0.21% to 0.31%. 
There was less mortality (1.07% in MS patients versus 2.97% 
in non-MS patients, P,0.0001, Table 1) and a lower rate 
of discharge to nursing home or rehabilitation (69.25% for 
MS patients versus 72.17% for non-MS patients, P,0.0001, 
Table 1) for persons with MS. The effect of time did not 
result in significant differences in mortality and discharge 
disposition. With indirect standardization, the prevalence of 
MS among patients with hip fracture was 2.844 (95% con-
fidence interval [CI] 2.837–2.852, Table 2) predicted when 
age-adjusted, 2.505 (95% CI 2.499–2.512, Table 2) when sex-
adjusted and age-adjusted, and 2.175 (95% CI 2.168–2.182, 
Table 2) when sex-adjusted and race-adjusted (white, black). 
Race was specified for 65% of the sample.
Table 1 comparison of median age, sex, discharge disposition, 
and mortality for people with and without multiple sclerosis
Non-MS, n=1,063,773 MS, n=2,631
Median age (iQr)* 82 (95% ci 75–87) 65 (95% ci 58–73)
Female** 74.82% 79.17%
Male** 25.18% 20.83%
Discharge disposition**
 routine 14.29% 15.07%
 Transfer 2.68% 2.70%
 long-term care 72.17% 69.25%
 Home health 7.52% 11.26%
 Other 0.38% 0.64%
 Mortality 2.97% 1.07%
Notes: routine discharge refers to discharge to home, long-term care discharge refers 
to discharge to a nursing home or rehabilitation center, and other discharge refers 
to discharge against medical advice or destination not known. all comparisons are 
statistically significant at a P-value of ,0.001. *P,0.001 (Wilcoxon); **P,0.001 (χ2). 
Abbreviations: IQR, interquartile range; CI, confidence interval; MS, multiple 
sclerosis.
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Discussion
Data from this retrospective study encompassing hospital 
admissions in the USA over 20 years suggest an increased 
fracture risk in MS patients. This prevalence was over two 
times greater than in the non-MS cohort and was similar 
to findings from the English National Hospital Episode 
 Statistics database which demonstrated a relative risk for 
femoral fracture of 2.79 in patients with MS.7 MS patients 
were also significantly younger at time of fracture, with a 
median age of 65 years for MS patients versus 82 years for 
non-MS patients. These younger MS patients are less likely 
to have comorbidities than their non-MS counterparts, which 
helps to explain their reduced need for discharge to a nursing 
home and reduced mortality.
Previous studies have shown decreased BMD from 
hypovitaminosis D and glucocorticoid treatment in patients 
with MS.3,10 In addition, people with MS are also at increased 
risk for fractures due to frequent falls as a result of reduced 
muscle strength, visual deficits, and problems with balance 
and coordination. In fact, a 2009 study revealed that 72% of 
women with MS self-reported impaired mobility after the 
age of 50 years.11 Studies have also shown reduced BMD 
measurements in secondary progressive MS when compared 
with relapsing-remitting MS, suggesting that a longer dura-
tion of disease may result in greater accrual of risk factors 
and worsening BMD.1
The World Health Organization developed the FRAX 
tool to identify patients aged 40–90 years at risk for a major 
osteoporotic fracture or hip fracture at 10 years.12 The FRAX 
incorporates individual risk factors that increase the risk for 
osteoporosis, such as glucocorticoid use, history of fractures, 
smoking, and alcohol use to allow identification of individuals 
at greatest risk for fracture. However, the FRAX calculator 
does not account for risk factors commonly found in MS and 
other debilitating diseases, such as Parkinson’s disease, that 
result in higher fracture rates, such as immobility, imbalance, 
frequent falls, and low vitamin D status.5 Thus, even though 
MS patients have higher rates of hip fractures as shown in our 
study, the calculated FRAX score underestimates the 10-year 
fracture risk for persons with MS. Clinicians should assess 
for the presence of these specific risks to allow for risk factor 
modification, subsequent prevention of future fractures, and 
early initiation of treatment for osteoporosis.
In addition to this, clinicians should promote physical 
activity because immobility is a significant part of MS, and 
these patients have bone loss due to a lack of mechanical 
stress-related loading and off-loading that induces osteoblast 
bone formation and maintenance.3,12
The strengths of our study include it being a large retro-
spective analysis over 20 years. Its limitations include a lack 
of information on preadmission functional status, medica-
tion use, severity and duration of MS, and the rate of falls in 
the MS cohort compared with the non-MS cohort. Further 
stratification of MS patients using information on specific 
risk factors, such as number of falls, level of mobility, and 
other known contributors to low BMD such as vitamin D 
status and type of MS, will enable identification of signifi-
cant risk factor(s) and early intervention to improve BMD 
and fracture rate.
Conclusion
People with MS have a greater than two times higher risk 
for fractures that is independent of age, sex, and race, and 
they are sustaining these fractures at a significantly younger 
age. Several unique risk factors have been suggested for the 
increased fracture risk and lower BMD in patients with MS. 
These risk factors are not included in the FRAX calculation, 
resulting in an underestimation of the 10-year fracture risk in 
patients with MS. Thus, health care providers who encounter 
MS patients, such as physical therapists, neurologists, ortho-
pedic surgeons, and endocrinologists, should incorporate 
these risk factors in their decision-making when determining 
the risk for osteoporotic fracture and initiation of therapy to 
prevent and/or treat osteoporosis in MS patients.
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